Ganciclovir (formerly DHPG) is the first drug to show any effectiveness against diseases caused by cytomegalovirus, which include congenital infection, and conditions almost invariably fatal to organ recipients and patients with AIDS. Reviews the preclinical and clinical studies on the drug"s pharma